SIRT1, a cellular stress sensor, a deacetylase, and a negative regulator of TP53, has been shown to contribute to chemotherapy resistance in AML cells by reducing the intracellular level of O2•-[131,132]. This evidence concerns the gene SIRT1 and acute myeloid leukemia.